Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide banner about the government funding lapse and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check9 days agoChange DetectedIntroduced a glossary toggle (Show glossary) and updated minor UI labels (capitalization of 'Data' terms). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4, updating the displayed revision label to Revision: v3.3.4.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a new release note 'Revision: v3.3.3' in the page footer. Removed the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' release note.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page no longer shows the government funding status/operating status notice. This change does not affect the trial details, inclusion criteria, or listed locations.SummaryDifference0.4%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.